Biodesix
BDSX
38 hedge funds and large institutions have $34.1M invested in Biodesix in 2023 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 13 increasing their positions, 11 reducing their positions, and 3 closing their positions.
67% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 3
18% more repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 11
11% more capital invested
Capital invested by funds: $30.7M → $34.1M (+$3.34M)
3% more funds holding
Funds holding: 37 → 38 (+1)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
0% more call options, than puts
Call options by funds: $1K | Put options by funds: $1K
0.16% less ownership
Funds ownership: 1.1% → 0.94% (-0.16%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
+$124K |
| 2 |
TAM
Telemark Asset Management
Boston,
Massachusetts
|
+$119K |
| 3 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$93K |
| 4 |
Millennium Management
New York
|
+$90.6K |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$77.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACM
AIGH Capital Management
Baltimore,
Maryland
|
-$389K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$330K |
| 3 |
EIM
Essex Investment Management
Boston,
Massachusetts
|
-$162K |
| 4 |
WVP
Worth Venture Partners
Fort Lee,
New Jersey
|
-$95.1K |
| 5 |
HF
HRT Financial
New York
|
-$61K |
BDSX Hedge Fund Activity: Q4 2023 in Review
38 of the 6,869 institutional investors tracked by Wall St. Rank reported a position in Biodesix (BDSX) for Q4 2023, worth a combined $34.1M — up 11% from $30.7M a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new BDSX positions and 3 closed out — a net gain of 2 holders — while 13 added to existing stakes and 11 trimmed.
The largest buyer was Geode Capital Management, adding an estimated $124K. The largest seller was AIGH Capital Management, cutting an estimated $389K.
- 38 institutional investors held Biodesix (BDSX) as of Q4 2023, up from 37 in Q3 2023.
- Funds reported $34.1M of Biodesix stock for Q4 2023, up 11% quarter-over-quarter.
- 5 funds opened new Biodesix positions in Q4 2023 and 3 closed out, a net change of +2 holders.
- The largest Biodesix buyer in Q4 2023 was Geode Capital Management, an estimated $124K added.
- The largest Biodesix seller in Q4 2023 was AIGH Capital Management, an estimated $389K sold.
Based on aggregated 13F filings for Q4 2023.